Ayako Arai

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 12

Top Topics

Platelet Rich Plasma

Hematopoietic Stem Cell

Top Venues

British journal of haematology

American journal of hematology

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Yotaro Motomura, Kota Yoshifuji, Takayoshi Tachibana, Hiroshi Takase, Ayako Arai, Keisuke Tanaka, Keigo Okada, Ayako Nogami, Yoshihiro Umezawa, Chizuko Sakashita, Masahide Yamamoto, Takehiko Mori, Toshikage Nagao
Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma. British journal of haematology 204 (4) (2023)
Yu Uemura, Kumi Oshima, Aika Fuseya, Akane Hosokai, Ayaka Ohashi, Masatoshi Kanno, Ayako Arai
Aortitis after administration of pegfilgrastim to a healthy donor for peripheral blood stem cell collection. International journal of hematology (2023)
Yotaro Motomura, Kota Yoshifuji, Takayoshi Tachibana, Hiroshi Takase, Ayako Arai, Keisuke Tanaka, Keigo Okada, Ayako Nogami, Yoshihiro Umezawa, Chizuko Sakashita, Masahide Yamamoto, Takehiko Mori, Toshikage Nagao
Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma. British journal of haematology (2023)
Yotaro Motomura, Kota Yoshifuji, Takayoshi Tachibana, Hiroshi Takase, Ayako Arai, Keisuke Tanaka, Keigo Okada, Ayako Nogami, Yoshihiro Umezawa, Chizuko Sakashita, Masahide Yamamoto, Takehiko Mori, Toshikage Nagao
Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma. British journal of haematology 204 (4) (2023)
Yoji Hirai, Hideo Asada, Toshihisa Hamada, Jun-Ichi Kawada, Hiroshi Kimura, Ayako Arai, Koichi Ohshima, Shouichi Ohga, Keiji Iwatsuki, null null
Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy. The Journal of dermatology (2023)
Masahide Yamamoto, Maho Sato, Yasushi Onishi, Yoji Sasahara, Hideki Sano, Masayoshi Masuko, Hirohisa Nakamae, Ken-Ichi Matsuoka, Takahide Ara, Kana Washio, Makoto Onizuka, Kenichiro Watanabe, Yoshiyuki Takahashi, Tsuneaki Hirakawa, Miwako Nishio, Chizuko Sakashita, Tohru Kobayashi, Akihisa Sawada, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Hashii, Yoshiko Atsuta, Ayako Arai
Registry data analysis of hematopoietic stem cell transplantation on systemic chronic active Epstein-Barr virus infection patients in Japan. American journal of hematology 97 (6) (2022)
Ayako Arai
Chronic Active Epstein-Barr Virus Infection: The Elucidation of the Pathophysiology and the Development of Therapeutic Methods. Microorganisms 9 (1) (2021)
Manabu Matsunawa, Yasuyuki Inoue, Kunihiro Yagihashi, Yoshio Aida, Akiko Uchida, Yu Uemura, Yusuke Saiki, Madoka Takimoto, Fumiaki Sano, Ikuo Miura, Ayako Arai
The clinicopathological analysis of organising pneumonia in myelodysplastic syndrome: high frequency in der(1;7)(q10; p10). British journal of haematology 194 (1) (2021)
Mayumi Yoshimori, Miwako Nishio, Ayaka Ohashi, Megumi Tateishi, Ayaka Mimura, Naomi Wada, Minori Saito, Norio Shimizu, Ken-Ichi Imadome, Ayako Arai
Interferon-γ Produced by EBV-Positive Neoplastic NK-Cells Induces Differentiation into Macrophages and Procoagulant Activity of Monocytes, Which Leads to HLH. Cancers 13 (20) (2021)
Ayako Arai, Hiroshi Takase, Mayumi Yoshimori, Kouhei Yamamoto, Manabu Mochizuki, Osamu Miura
Gene expression profiling of primary vitreoretinal lymphoma. Cancer science 111 (4) (2020)
Ichiro Yonese, Hiroshi Takase, Mayumi Yoshimori, Erika Onozawa, Akiho Tsuzura, Tohru Miki, Manabu Mochizuki, Osamu Miura, Ayako Arai
CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential. European journal of haematology 102 (2) (2018)
Honami Takada, Ken-Ichi Imadome, Haruna Shibayama, Mayumi Yoshimori, Ludan Wang, Yasunori Saitoh, Shin Uota, Shoji Yamaoka, Takatoshi Koyama, Norio Shimizu, Kouhei Yamamoto, Shigeyoshi Fujiwara, Osamu Miura, Ayako Arai
EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells. PloS one 12 (3) (2017)